chr17-47307584-C-T
Variant summary
Our verdict is Pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPP4_Strong
This summary comes from the ClinGen Evidence Repository: The NM_000212.2:c.2248C>T variant is a nonsense variant that results in premature termination of translation; however, NMD is not predicted. The variant is reported at a frequency of 0.0006008 in gnomAD v2.1.1 in the African population and does not meet PM2 or BS1 (PM2 threshold: <0.0001; BS1 threshold >0.00158). The variant is observed in one homozygous and 3 compound heterozygous individuals in the literature and from internal laboratory data (PMID:20106508, 9351872, 30138987); however, evidence from the in-trans variatns is not applicable as Arg750Ter does not meet PM2. Functional evidence from PMID:9351872 shows that the variant-expressing CHO cells bind fibrinogen but fail to spread on fibrinogen-coated surface. In summary, the Arg750Ter variant is classified as pathogenic. GT-specific criteria applied: PVS1_Strong, PP4_Strong. LINK:https://erepo.genome.network/evrepo/ui/classification/CA123246/MONDO:0010119/011
Frequency
Consequence
ENST00000559488.7 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGB3 | NM_000212.3 | c.2248C>T | p.Arg750Ter | stop_gained | 14/15 | ENST00000559488.7 | NP_000203.2 | |
EFCAB13-DT | NR_110880.1 | n.363-3802G>A | intron_variant, non_coding_transcript_variant | |||||
EFCAB13-DT | NR_110881.1 | n.227-3802G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGB3 | ENST00000559488.7 | c.2248C>T | p.Arg750Ter | stop_gained | 14/15 | 1 | NM_000212.3 | ENSP00000452786 | P1 | |
EFCAB13-DT | ENST00000575039.1 | n.227-3802G>A | intron_variant, non_coding_transcript_variant | 5 | ||||||
ITGB3 | ENST00000696963.1 | c.2248C>T | p.Arg750Ter | stop_gained | 14/14 | ENSP00000513002 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000437 AC: 11AN: 251438Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135888
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727244
GnomAD4 genome AF: 0.000151 AC: 23AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74408
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 18, 2022 | Nonsense variant predicted to result in protein truncation in a gene for which loss of function is a known mechanism of disease; Also known as c.2268C>T, p.(R724X); This variant is associated with the following publications: (PMID: 25525159, 31589614, 9351872, 20106508, 30138987, 32089034) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change creates a premature translational stop signal (p.Arg750*) in the ITGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ITGB3 are known to be pathogenic (PMID: 21917754). This variant is present in population databases (rs121918450, gnomAD 0.06%). This premature translational stop signal has been observed in individual(s) with clinical features of autosomal recessive ITGB3-related conditions (PMID: 9351872, 20106508). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 13564). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects ITGB3 function (PMID: 9351872). For these reasons, this variant has been classified as Pathogenic. - |
Glanzmann thrombasthenia Pathogenic:1
Pathogenic, reviewed by expert panel | curation | ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen | Oct 01, 2021 | The NM_000212.2:c.2248C>T variant is a nonsense variant that results in premature termination of translation; however, NMD is not predicted. The variant is reported at a frequency of 0.0006008 in gnomAD v2.1.1 in the African population and does not meet PM2 or BS1 (PM2 threshold: <0.0001; BS1 threshold >0.00158). The variant is observed in one homozygous and 3 compound heterozygous individuals in the literature and from internal laboratory data (PMID: 20106508, 9351872, 30138987); however, evidence from the in-trans variatns is not applicable as Arg750Ter does not meet PM2. Functional evidence from PMID: 9351872 shows that the variant-expressing CHO cells bind fibrinogen but fail to spread on fibrinogen-coated surface. In summary, the Arg750Ter variant is classified as pathogenic. GT-specific criteria applied: PVS1_Strong, PP4_Strong. - |
Glanzmann thrombasthenia 2 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1997 | - - |
Platelet-type bleeding disorder 16 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 10, 2018 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Dec 17, 2024 | - - |
Glanzmann thrombasthenia 1 Pathogenic:1
Pathogenic, no assertion criteria provided | research | ISTH-SSC Genomics in Thrombosis and Hemostasis, KU Leuven, Center for Molecular and Vascular Biology | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at